Alexandra Balcom Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 20 hours ago
Alexandra Balcom has an estimated net worth of at least $13.3 million*, as of Jan. 22, 2025. They own 61,734 shares of NUVL stock. They have sold 109,016 shares of NUVL stock since 2021, for an estimated $8.3 million.
Alexandra Balcom $NUVL SEC Form 4 Insider Trading
Alexandra Balcom has filed a total of 24 insider trades in $NUVL since 2021. Their most recent trade was a sale of 2,173 shares, made on Jan 06, 2025. Their largest trade was a sale of 30,000 shares, made on Dec 18, 2023. We estimate that they now own 61,734 shares of $NUVL, worth an estimated $4.9 million.
Insider Trading at $NUVL
There have been a total of 313 insider trades reported at $NUVL since 2021, with 1.5 million shares purchased and 5.6 million shares sold. The most active insider traders in $NUVL stock have been Deborah Ann Miller, Darlene Noci, and Alexandra Balcom. The most recent trade was a sale of 9,358 shares reported by James Richard Porter (President and CEO), made on Jan 15, 2025.
History of Insider Stock Trades by Alexandra Balcom
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NUVL
|
Sale | 2,173 | Jan 06, 2025 | Jan. 8, 2025, 5:48 p.m. |
|
NUVL
|
Sale | 691 | Jan 06, 2025 | Jan. 8, 2025, 5:48 p.m. |
|
NUVL
|
Sale | 1,152 | Jan 06, 2025 | Jan. 8, 2025, 5:48 p.m. |
|
NUVL
|
Sale | 1,858 | Nov 29, 2024 | Dec. 3, 2024, 5:46 p.m. |
|
NUVL
|
Sale | 8,142 | Nov 29, 2024 | Dec. 3, 2024, 5:46 p.m. |
|
NUVL
|
Sale | 1,600 | Oct 31, 2024 | Nov. 4, 2024, 5:46 p.m. |
|
NUVL
|
Sale | 100 | Oct 31, 2024 | Nov. 4, 2024, 5:46 p.m. |
|
NUVL
|
Sale | 1,980 | Oct 31, 2024 | Nov. 4, 2024, 5:46 p.m. |
|
NUVL
|
Sale | 6,320 | Oct 31, 2024 | Nov. 4, 2024, 5:46 p.m. |
|
NUVL
|
Sale | 5,032 | Sep 30, 2024 | Oct. 2, 2024, 5:33 p.m. |
|
NUVL
|
Sale | 2,963 | Sep 30, 2024 | Oct. 2, 2024, 5:33 p.m. |
|
NUVL
|
Sale | 700 | Sep 30, 2024 | Oct. 2, 2024, 5:33 p.m. |
|
NUVL
|
Sale | 1,305 | Sep 30, 2024 | Oct. 2, 2024, 5:33 p.m. |
|
NUVL
|
Sale | 5,231 | Aug 30, 2024 | Sept. 4, 2024, 4:52 p.m. |
|
NUVL
|
Sale | 4,481 | Aug 30, 2024 | Sept. 4, 2024, 4:52 p.m. |
|
NUVL
|
Sale | 288 | Aug 30, 2024 | Sept. 4, 2024, 4:52 p.m. |
|
NUVL
|
Sale | 1,649 | Jul 31, 2024 | Aug. 2, 2024, 4:43 p.m. |
|
NUVL
|
Sale | 1,135 | Jul 31, 2024 | Aug. 2, 2024, 4:43 p.m. |
|
NUVL
|
Sale | 5,723 | Jul 31, 2024 | Aug. 2, 2024, 4:43 p.m. |
|
NUVL
|
Sale | 896 | Jul 31, 2024 | Aug. 2, 2024, 4:43 p.m. |
|
NUVL
|
Sale | 597 | Jul 31, 2024 | Aug. 2, 2024, 4:43 p.m. |
|
NUVL
|
Sale | 30,000 | Dec 18, 2023 | Dec. 20, 2023, 5:51 p.m. |
|
NUVL
|
Sale | 14,152 | Jul 31, 2023 | Aug. 1, 2023, 4:16 p.m. |
|
NUVL
|
Sale | 10,848 | Jul 31, 2023 | Aug. 1, 2023, 4:16 p.m. |
$NUVL Executives and Stock Owners with Insider Trades
-
Deborah Ann Miller, Chief Legal Officer
-
Darlene Noci, Chief Development Officer
-
Alexandra Balcom, Chief Financial Officer
-
James Richard Porter, President and CEO
-
Christopher Durant Turner, Chief Medical Officer
-
Henry E. Pelish, Chief Scientific Officer
-
Darlene Noci, See Remarks
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.